MIM
FN icon

MetLife Investment Management’s Fabrinet FN Stock Holding History

MetLife Investment Management’s Portfolio FN Stock Details FN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Sell
18,658
-18,016
-49% -$11.6M 0.05% 372
2026
Q1 		$19.1M Sell
36,674
-134
-0.4% -$68.1K 0.1% 177
2025
Q4 		$16.8M Sell
36,808
-1,973
-5% -$858K 0.08% 218
2025
Q3 		$14.1M Sell
38,781
-1,440
-4% -$474K 0.07% 268
2025
Q2 		$11.9M Sell
40,221
-316
-0.8% -$70.4K 0.07% 267
2025
Q1 		$8.01M Sell
40,537
-1,238
-3% -$270K 0.04% 413
2024
Q4 		$9.19M Buy
41,775
+3,016
+8% +$727K 0.05% 288
2024
Q3 		$9.16M Buy
38,759
+17,734
+84% +$4.1M 0.05% 279
2024
Q2 		$5.15M Buy
21,025
+2,141
+11% +$454K 0.03% 467
2024
Q1 		$3.57M Sell
18,884
-399
-2% -$80K 0.02% 681
2023
Q4 		$3.67M Sell
19,283
-223
-1% -$38.2K 0.03% 658
2023
Q3 		$3.25M Hold
19,506
– – 0.03% 667
2023
Q2 		$2.53M Buy
19,506
+137
+0.7% +$14.6K 0.02% 835
2023
Q1 		$2.3M Hold
19,369
– – 0.02% 866
2022
Q4 		$2.48M Hold
19,369
– – 0.02% 810
2022
Q3 		$1.85M Hold
19,369
– – 0.02% 913
2022
Q2 		$1.57M Hold
19,369
– – 0.01% 995
2022
Q1 		$2.04M Buy
19,369
+6,927
+56% +$732K 0.01% 982
2021
Q4 		$1.47M Sell
12,442
-678
-5% -$75.1K 0.01% 968
2021
Q3 		$1.34M Hold
13,120
– – 0.01% 997
2021
Q2 		$1.26M Sell
13,120
-1,252
-9% -$112K 0.01% 1052
2021
Q1 		$1.3M Hold
14,372
– – 0.01% 1018
2020
Q4 		$1.12M Sell
14,372
-1,412
-9% -$96K 0.01% 1077
2020
Q3 		$995K Hold
15,784
– – 0.01% 1030
2020
Q2 		$985K Buy
15,784
+759
+5% +$46.6K 0.01% 1045
2020
Q1 		$820K Sell
15,025
-1,245
-8% -$75.2K 0.01% 987
2019
Q4 		$1.05M Hold
16,270
– – 0.01% 1076
2019
Q3 		$851K Buy
16,270
+1,342
+9% +$70.3K 0.01% 1149
2019
Q2 		$741K Hold
14,928
– – 0.01% 1260
2019
Q1 		$782K Hold
14,928
– – ﹤0.01% 1806
2018
Q4 		$766K Hold
14,928
– – 0.01% 1130
2018
Q3 		$691K Buy
+14,928
New +$641K 0.01% 1327

Other funds holding FN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

MetLife Investment Management's FN Position: Q2 2026 in Review

MetLife Investment Management reduced its Fabrinet (FN) stake by 49% in Q2 2026, selling an estimated $11.6M and leaving 18,658 shares worth $10.5M. The position accounts for 0.05% of the portfolio, ranked #372.

MetLife Investment Management first reported a position in FN in Q3 2018 and has held it in 32 quarters since. The position peaked at $19.1M in Q1 2026. 760 funds tracked by Wall St. Rank hold FN as of Q2 2026.

  • MetLife Investment Management held 18,658 shares of Fabrinet worth $10.5M as of Q2 2026.
  • MetLife Investment Management sold 18,016 Fabrinet shares in Q2 2026, an estimated $11.6M.
  • Fabrinet made up 0.05% of MetLife Investment Management's portfolio in Q2 2026, its #372 holding.
  • MetLife Investment Management first reported a position in Fabrinet in Q3 2018 and has held it in 32 quarters since.
  • MetLife Investment Management's Fabrinet position peaked at $19.1M in Q1 2026.
  • 760 funds tracked by Wall St. Rank held Fabrinet as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.